Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.

导出 OA

翻译打印收藏纠错

作者： Gianluigi,Forloni ^[1] ; Ignazio,Roiter ^[2] ; Vladimiro,Artuso ^[2] ; Manuel,Marcon ^[3] ; Walter,Colesso ^[3] ; Elviana,Luban ^[3] ; Ugo,Lucca ^[1] ; Mauro,Tettamanti ^[1] ; Elisabetta,Pupillo ^[1] ; Veronica,Redaelli ^[4] ; Francesco,Mariuzzo ^[3] ; Giulia,Boscolo Buleghin ^[3] ; Alice,Mariuzzo ^[3] ; Fabrizio,Tagliavini ^[4] ; Roberto,Chiesa ^[1] ; Anna,Ambrosini ^[5]

作者单位： Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. ^[1] Ulss 2 Marca Trevigiana Ca' Foncello Hospital, Treviso, Italy. ^[2] AFIFF, Treviso, Italy. ^[3] Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy. ^[4] Fondazione Telethon ETS, Milano, Italy. ^[5]

关键词 clinical trial disease incidence genetic prion diseases patient engagement tetracyclines

主题词人类(Humans);失眠症, 致死性家族性(Insomnia, Fatal Familial);突变(Mutation);朊病毒病(Prion Diseases)

DOI 10.1080/19336896.2022.2083435

PMID 35737759

发布时间 2022-12-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交